Ashish Upadhyay MD
Clinical Professor, Nephrology
Program Director, Nephrology Fellowship Program
72 East Concord Street | (617) 638-6500ashish.upadhyay@bmc.org
ashishu@bu.edu
Sections
Nephrology
Centers
Evans Center for Interdisciplinary Biomedical Research
Biography
Dr. Upadhyay is a clinical nephrologist and Director of the Nephrology Fellowship Program at Boston Medical Center (BMC). He also leads the research and evidence-based medicine curriculum for the Internal Medicine Residency Program and is a key faculty in BU’s NIH R38-funded Research in Residency Program. Previously, Dr. Upadhyay led evidence review teams for international clinical practice guidelines in nephrology (2009-2012), served as Associate Director of the Internal Medicine Residency Program at BMC (2012-2018), and served as Director of the Nephrology Clerkship at BUCASM (2018-2025). His scholarly contributions span clinical nephrology and medical education, with his publications, excluding clinical practice guidelines, achieving over 6000 citations. In addition, he is an investigator on several kidney disease–related clinical studies at BMC. Nationally, he serves as a voting member of the Association for the Advancement of Medical Instrumentation’s Renal Disease and Detoxification Committee, the primary source of national and international consensus standards for hemodialysis technology and dialysis water sterilization processes. At BUCASM, he chairs the Committee on Appeals. He is the recipient of the 2021 Program Leadership Award from Boston Medical Center and the 2022 Robert Dawson Evans Special Recognition Teaching Award from the Department of Medicine.
Other Positions
Education
MBBS, Tribhuvan University
Publications
Upadhyay A, Waikar SS. AKI in 2026: Emerging Evidence and Evolving Clinical Practice. Nephrology Self-Assessment Program (nephSAP). American Society of Nephrology. 2026; 25(2):80-85.
Published on 6/11/2026Bharati J, Bosch NA, Upadhyay A. Empagliflozin versus dapagliflozin for kidney outcomes in stage 3 chronic kidney disease: a propensity score-matched multi-center cohort study. BMC Nephrol. 2026 Jun 11; 27(1). PMID: 42277683.
Published on 1/19/2026Verma A, Upadhyay A. Diabetic kidney disease, biomarkers, and finerenone. Diabetes Obes Metab. 2026 Apr; 28(4):2582-2593. PMID: 41555617.
Published on 11/20/2025Hudspeth JC, Bosch NA, Lowe RC, Simmons RP, Yadavalli GK, Upadhyay A. Changing the Presentation of Overnight Admissions to Improve Teaching Rounds. J Gen Intern Med. 2026 May; 41(6):1657-1660. PMID: 41264075.
Published on 3/1/2025Bharati J, Baldino MC, Upadhyay A. A Young Man With an Unusual Pulmonary-Renal Syndrome: A Quiz. Am J Kidney Dis. 2025 Mar; 85(3):A16-A18. PMID: 39986701.
Published on 9/20/2024Upadhyay A, Haider L. Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease: Clinical Evidence and Potential Adverse Events. Clin Diabetes. 2025; 43(1):43-52. PMID: 39829701.
Published on 4/12/2024Karabulut K, Upadhyay A. Rhabdomyolysis: A lesser-known complication of hyperosmolar hyperglycemic coma. Journal of Clinical Images and Medical Case Reports. 2024; 4(5):2984.
Published on 3/25/2024Upadhyay A. SGLT2 Inhibitors and Kidney Protection: Mechanisms Beyond Tubuloglomerular Feedback. Kidney360. 2024 May 01; 5(5):771-782. PMID: 38523127.
Published on 1/14/2023Kamel MH, Upadhyay A, Borkan SC. Intractable hyponatremia complicated by a reset osmostat: a case report. J Med Case Rep. 2023 Jan 14; 17(1):13. PMID: 36639685.
Published on 1/1/2022Bonner R, Stewart J, Upadhyay A, Bruce RD, Taylor JL. A Primary Care Intervention to Increase HIV Pre-Exposure Prophylaxis (PrEP) Uptake in Patients with Syphilis. J Int Assoc Provid AIDS Care. 2022 Jan-Dec; 21:23259582211073393. PMID: 35001723.
Media Mentions
Published on 9/3/2026
Earlier SGLT2 Use After Dialysis-Requiring AKI May Improve Kidney Outcomes in Patients With T2D
View full list of 1 media mentions.